Dynamic antigen expression and cytotoxic T cell resistance in HIV reservoir clones
|
Clonally expanded CD4+ T-cells harboring rebound-competent
HIV persist lifelong during ART1-5. Latency is considered the
principal barrier to ... |
New approach to HIV treatment offers hope to reduce daily drug needs
More than 30 million people with HIV must take antiretroviral therapy (ART) medications daily to keep the virus under control, according to the ... View article...